Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.37 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3686301 | 0.90 | LMNA (0.44) | HIF1ACALM1TSHRALDH1A1LOXL2 | |
| SCHEMBL8965651 | 0.87 | HTT (0.42) | HIF1ACALM1ALDH1A1LOXL2IDO1 | |
| SCHEMBL8056836 | 0.87 | HTT (0.42) | HIF1ACALM1ALDH1A1LOXL2IDO1 | |
| Hydrochloric Acid SCHEMBL11775352 | 0.87 | LMNA (0.42) | HIF1ACALM1TSHRALDH1A1LOXL2 | |
| Hydrochloric Acid SCHEMBL11771900 | 0.85 | HTT (0.41) | HIF1ACALM1ALDH1A1IDO1CYP2D6 | |
| SCHEMBL13326546 | 0.78 | HIF1A (0.58) | HIF1ACALM1TSHRALDH1A1LOXL2 | |
| SCHEMBL486989 | 0.77 | ALDH1A1 (0.52) | TSHRALDH1A1TP53HPGDALOX15 | |
| SCHEMBL14587060 | 0.77 | LMNA (0.46) | HIF1ATSHRALDH1A1CYP2D6CHRNB2 | |
| SCHEMBL1964501 | 0.77 | CHRNA7 (0.44) | HIF1ATP53CYP2D6CHRNB2CHRNA4 | |
| SCHEMBL2063309 | 0.77 | TSHR (0.41) | HIF1ACALM1TSHRALDH1A1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2448952-B1 | NOVEL GUANOSINE-RICH MODIFIED OLIGONUCLEOTIDES AND ANTIPROLIFERATIVE ACTIVITY THEREOF | APTABIO THERAPEUTICS INC (KR) | 2016-10-12 | — | — | EP | disclosed |
| US-9221781-B2 | Synthesis of polyhydroxy chromenone compounds and their anti-tumor effects | BEIJING SHENOGEN PHARAM GROUP LTD. (CN) | 2015-12-29 | — | — | US | disclosed |
| US-9056886-B2 | Guanosine-rich modified oligonucleotides and antiproliferative activity thereof | APTABIO THERAPEUTICS INC. (KR) | 2015-06-16 | — | — | US | disclosed |
| US-20150119251-A1 | AGRICULTURAL PLANT-PROTECTING AGENTS CONTAINING DIPEPTIDE DERIVATIVE AS ACTIVE INGREDIENT | REPUBLIC OF KOREA (RURAL DEVELOPMENT ADMINISTRATION) (KR) | 2015-04-30 | — | — | US | disclosed |
| US-20150011618-A1 | SYNTHESIS OF POLYHYDROXY CHROMENONE COMPOUNDS AND THEIR ANTI-TUMOR EFFECTS | BEIJING SHENOGEN PHARMA GROUP LTD. (CN) | 2015-01-08 | — | — | US | disclosed |
| US-20120202981-A1 | NOVEL GUANOSINE-RICH MODIFIED OLIGONUCLEOTIDES AND ANTIPROLIFERATIVE ACTIVITY THEREOF | APTABIO THERAPEUTICS INC. (KR) | 2012-08-09 | — | — | US | disclosed |
| EP-2448952-A2 | NOVEL GUANOSINE-RICH MODIFIED OLIGONUCLEOTIDES AND ANTIPROLIFERATIVE ACTIVITY THEREOF | Aptabio Therapeutics Inc. (KR) | 2012-05-09 | — | — | EP | disclosed |
| US-20110130550-A1 | PROTEIN MONOMER, PROTEIN POLYMER OBTAINED FROM SAID MONOMER, AND DEVICE THAT CONTAINS THEM | OSAKA UNIVERSITY (JP) | 2011-06-02 | — | — | US | disclosed |
| EP-2272867-A1 | PROTEIN MONOMER, PROTEIN POLYMER OBTAINED FROM SAID MONOMER, AND DEVICE THAT CONTAINS THEM | Osaka University (JP) | 2011-01-12 | — | — | EP | disclosed |
| WO-2011002200-A2 | NOVEL GUANOSINE-RICH MODIFIED OLIGONUCLEOTIDES AND ANTIPROLIFERATIVE ACTIVITY THEREOF | APTABIO THERAPEUTICS INC. (KR) | 2011-01-06 | — | — | WO | disclosed |
| CN-1997361-A | Antitumor agent | ASTELLAS PHARMA INC (JP) | 2007-07-11 | — | — | CN | disclosed |
| CN-1802155-A | Nerve cell protective agent | EISAI CO LTD (JP) | 2006-07-12 | — | — | CN | disclosed |
| CN-1073089-C | Benzodiazepine derivatives, compositions thereof and their use in the manufacture of medicaments | SHIONOGI & CO (JP) | 2001-10-17 | — | — | CN | disclosed |
| CN-1261895-A | Cyclic azapeptide with angiogenic effect | MERCK PATENT GMBH (DE) | 2000-08-02 | — | — | CN | disclosed |
| CN-1143362-A | Novel benzodizaepine derivative | SHIONOGI & CO (JP) | 1997-02-19 | — | — | CN | disclosed |
| CN-1032292-C | Water-soluble antibiotic composition and water-soluble salts of new cephem compounds | FUJISAWA PHARMACEUTICAL CO (JP) | 1996-07-17 | — | — | CN | disclosed |
| EP-0658162-A1 | CARBAPENEM DERIVATIVES AND PROCESSES FOR PREPARING THE SAME | DONG-A PHARM. CO., LTD. (KR) | 1995-06-21 | — | — | EP | disclosed |
| CN-1041941-A | The preparation method of benzodiazepine derivatives | FUJISAWA PHARMACEUTICAL CO (JP) | 1990-05-09 | — | — | CN | disclosed |
| CN-1031231-A | The water soluble antibiotics composition and the water-soluble salt of new cephem compounds | FUJISAWA PHARMACEUTICAL CO (JP) | 1989-02-22 | — | — | CN | disclosed |
| EP-0111326-A1 | Process for the manufacture of chiral azetidinones | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1984-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110130550-A1 | PROTEIN MONOMER, PROTEIN POLYMER OBTAINED FROM SAID MONOMER, AND DEVICE THAT CONTAINS THEM | MAX, MLX, MRPL21 | HIF1A 2826/4885CALM1 216/4885TSHR 2451/4885 |
| US-20150119251-A1 | AGRICULTURAL PLANT-PROTECTING AGENTS CONTAINING DIPEPTIDE DERIVATIVE AS ACTIVE INGREDIENT | PEPD, DNPEP, DPP7 | HIF1A 2623/4885CALM1 1474/4885TSHR 3540/4885 |
| US-20120202981-A1 | NOVEL GUANOSINE-RICH MODIFIED OLIGONUCLEOTIDES AND ANTIPROLIFERATIVE ACTIVITY THEREOF | RNMT, RNASE1, NSUN2 | HIF1A 3775/4885CALM1 3107/4885TSHR 4009/4885 |
| US-20150011618-A1 | SYNTHESIS OF POLYHYDROXY CHROMENONE COMPOUNDS AND THEIR ANTI-TUMOR EFFECTS | ESR1, GPER1, ESR2 | HIF1A 514/4885CALM1 1928/4885TSHR 500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.